FV HR2 Haplotype as Additional Inherited Risk Factor for Deep Vein Thrombosis in Individuals with a High-Risk Profile

Summary A number of strongly linked polymorphisms within the Factor V gene (FV HR2 haplotype) has been identified as a cause of resistance to activated protein C, and has suggested a modest risk factor for vein thrombosis. We investigated the frequency of the HR2 haplotype in 433 consecutive patients with confirmed deep vein thrombosis and 326 controls. The HR2 haplotype was more frequent in patients (15.2%) than in controls (10.1%). The risk of thrombosis among carriers of this haplotype was significantly increased (odds ratio: 1.6 [95% CI: 1.0-2.5]). The estimated risk associated with the HR2 haplotype was 1.8 (95% CI: 1.1-2.9) in subjects with (n = 255), and 1.4 (95% CI: 0.8-2.4) in those without (n = 178) acquired risk factors for vein thrombosis. After adjustment for sex, FV Leiden and FII A20210 mutations, the estimated risk of vein thrombosis among carriers of the HR2 haplotype was 1.8 (95% CI: 1.1-2.8). Present data indicate that the HR2 haplotype is independently associated with vein thrombosis among individuals with a highrisk profile.

[1]  D. Girelli,et al.  Functional Properties of Factor V and Factor Va Encoded by the R2-gene , 2001, Thrombosis and Haemostasis.

[2]  F. Rosendaal,et al.  The HR2 Haplotype of Factor V: Effects on Factor V Levels, Normalized Activated Protein C Sensitivity Ratios and the Risk of Venous Thrombosis , 2000, Thrombosis and Haemostasis.

[3]  D. Girelli,et al.  Mutations in the R2 FV Gene Affect the Ratio between the Two FV Isoforms in Plasma , 2000, Thrombosis and Haemostasis.

[4]  T. Baglin,et al.  The Factor V R2 Allele: Risk of Venous Thromboembolism, Factor V Levels and Resistance to Activated Protein C , 2000, Thrombosis and Haemostasis.

[5]  F R Rosendaal,et al.  Risk Factors for Venous Thrombotic Disease , 1999, Thrombosis and Haemostasis.

[6]  A. Tosetto,et al.  Activated Protein C Resistance and Factor V Leiden Mutation Are Independent Risk Factors for Venous Thromboembolism , 1999, Annals of Internal Medicine.

[7]  F. Rosendaal,et al.  A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. , 1999, Blood.

[8]  V. Nicaud,et al.  The Factor V Gene A4070G Mutation and the Risk of Venous Thrombosis , 1999, Thrombosis and Haemostasis.

[9]  M. Margaglione,et al.  Increased Risk for Venous Thrombosis in Carriers of the Prothrombin GA20210 Gene Variant , 1998, Annals of Internal Medicine.

[10]  M. Margaglione,et al.  The Methylenetetrahydrofolate Reductase TT677 Genotype Is Associated with Venous Thrombosis Independently of the Coexistence of the FV Leiden and the Prothrombin , 1998, Thrombosis and Haemostasis.

[11]  M. Makris,et al.  Co-inheritance of the 20210A Allele of the Prothrombin Gene Increases the Risk of Thrombosis in Subjects with Familial Thrombophilia , 1997, Thrombosis and Haemostasis.

[12]  A. Cumming,et al.  The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population , 1997, British journal of haematology.

[13]  E. Sacchi,et al.  A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. , 1997, Blood.

[14]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[15]  P. Mannucci,et al.  Inherited Thrombophilia: Part 1 , 1996, Thrombosis and Haemostasis.

[16]  J. Rosing,et al.  Factor V Enhances the Cofactor Function of Protein S in the APC-Mediated Inactivation of Factor VIII: Influence of the Factor VR506Q Mutation , 1996, Thrombosis and Haemostasis.

[17]  A. Tosetto,et al.  Validated questionnaire for the identification of previous personal or familial venous thromboembolism. , 1996, American journal of epidemiology.

[18]  P. Mannucci,et al.  Inherited thrombophilia: pathogenesis, clinical syndromes, and management. , 1996, Blood.

[19]  P. Reitsma,et al.  Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency , 1996, Thrombosis and Haemostasis.

[20]  N. Dzimiri,et al.  World distribution of factor V Leiden , 1996, The Lancet.

[21]  P. Reitsma,et al.  Factor V Leiden: An Additional Risk Factor for Thrombosis in Protein S Deficient Families? , 1995, Thrombosis and Haemostasis.

[22]  J. Griffin,et al.  Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERM. , 1995, Blood.

[23]  P. Reitsma,et al.  Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. , 1994, Blood.

[24]  J. Birkmeyer,et al.  The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. , 1994, Archives of internal medicine.

[25]  J. Miletich,et al.  Inherited predisposition to thrombosis , 1993, Cell.

[26]  H. Büller,et al.  Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. , 1990, The New England journal of medicine.